Bioventus Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Exagen Inc. (XGN)
Last exagen inc. earnings: 3/25 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Strategic Performance and Transformation Drivers Management characterizes the company as having completed a three-year transformation, shifting from foundational stabilization to an 'exciting new phase' focused on building a $1 billion medtech leader. The 10% organic revenue growth in Q4 was attributed to sharpened commercial execution and the successful realization of a planned second-half acceleration. Pain Treatments growth was primarily driven by volume increases in Duralane, benefiting from a market shift toward single-injection viscosupplementation and successful account wins. Restorative Therapies achieved its highest organic growth in seven years, which management credits to disciplined execution and the clinical impact of the Exagen product line. Profitability expansion of 490 basis points in Q4 resulted from a combination of high-margin product mix, operational efficiencies, and the divestiture of the lower-margin Advanced Rehabilitation business. International
Show less
Read more
Impact Snapshot
Event Time:
XGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XGN alerts
High impacting Exagen Inc. news events
Weekly update
A roundup of the hottest topics
XGN
News
- Exagen Inc. to Participate in Upcoming Investor ConferencesGlobeNewswire
- Exagen (NASDAQ:XGN) had its price target lowered by analysts at TD Cowen from $13.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026GlobeNewswire
- Exagen (NASDAQ:XGN) had its price target lowered by analysts at BTIG Research from $15.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
XGN
Earnings
- 11/4/25 - Miss
XGN
Sec Filings
- 3/4/26 - Form 4
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- XGN's page on the SEC website